TIAA FSB’s iShares Biotechnology ETF IBB Stock Holding History

TIAA FSB’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$330K	Buy	2,602 +305	+13%	+$39.6K	﹤0.01%	464
2023 Q1	$297K	Hold	2,297	–	–	﹤0.01%	483
2022 Q4	$302K	Sell	2,297 -10	-0.4%	-$1.29K	﹤0.01%	479
2022 Q3	$270K	Sell	2,307 -13	-0.6%	-$1.61K	﹤0.01%	489
2022 Q2	$273K	Buy	+2,320	New	+$275K	﹤0.01%	498

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

TIAA FSB's IBB Position: Q2 2023 in Review

TIAA FSB increased its iShares Biotechnology ETF (IBB) stake by 13% in Q2 2023, buying an estimated $39.6K and bringing the position to 2,602 shares worth $330K. The position accounts for ﹤0.01% of the portfolio, ranked #464.

TIAA FSB first reported a position in IBB in Q2 2022 and has held it in 5 quarters since. 843 funds tracked by Wall St. Rank hold IBB as of Q2 2023.

TIAA FSB held 2,602 shares of iShares Biotechnology ETF worth $330K as of Q2 2023.
TIAA FSB bought 305 iShares Biotechnology ETF shares in Q2 2023, an estimated $39.6K.
iShares Biotechnology ETF made up ﹤0.01% of TIAA FSB's portfolio in Q2 2023, its #464 holding.
TIAA FSB first reported a position in iShares Biotechnology ETF in Q2 2022 and has held it in 5 quarters since.
843 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2023.

Based on TIAA FSB's 13F filing for Q2 2023, filed 31 Jul 2023.